The difference between information and
expert, data-driven actionable intelligence

December 2015

Welcome to the December 2015 issue of CMC Market Outlook

This monthly e-newsletter provides valuable insights for both buyers and sellers of CMC drug development services. Our coverage will help you identify and understand market trends that will inform your strategic business perspective.

Enjoy the December issue, and happy holidays!

The PharmSource Team

 

CMO Investors Have More Money Than Places to Spend It

by Jim Miller, President, PharmSource

Consolidation is an obsession for contact manufacturing organization (CMO) executives, who worry about the competitive challenges posed by larger players; and for sourcing executives, who worry about the implications for supply chain security and relative pricing power. But will the CMO industry consolidate, and at what pace?

Consolidation is the process by which a shrinking number of companies control an increasing share of the available revenues in a given industry. It typically indicates a period where organic growth is slowing and where factors like economies of scale or brand recognition… read on
 

How big is the market for…?

This is a handy guide to frequently requested data about the bio/pharma contract services industry.

The market for absolute R&D growth:

Market Growth Source
2-3% Icon Plc
Presentation at William Blair 35th Annual Growth Stock Conference
June 2015

Read more about the size of the contract services market for various segments.
 

Coming Soon

Antibody-Drug Conjugates: Magic Bullet for the CDMO Industry?

PharmSource’s upcoming report – Antibody-Drug Conjugates (ADCs): Magic Bullet for the CDMO Industry? – is an indispensable resource for understanding the technical developments in the ADC sector and the scale of the commercial opportunities and risks for CMOs.

The CDMO sector is investing significant resources to expand its capabilities in the ADC arena. More than 20 companies are active in the sector although, to date, no single company… click here

User Tip

PharmSource Strategic Advantage

Did you know you can do a subject search in PharmSource Strategic Advantage for topics of specific interest to quickly find related articles published in our Outsourcing Reports?

To do this, select the Subject Search button in the left navigation bar of the Strategic Advantage Home page, then use the search box on the Archives page to enter a topic of interest. This will instantly provide direct links to all the articles published in Bio/Pharmaceutical Outsourcing Report and Emerging Markets Outsourcing Report that include the keywords you indicated.

You also can make a selection from the standard topic list on the Subject Search page. For example, you can click on Commercial Dose Manufacturing and receive a detailed list of articles on that topic.

For questions about this feature or any other inquiries, please contact our Director of Account Management, Blythe Moore, at +1.703.383.4903, ext. 104 | blythe.moore@pharmsource.com.
 


 

PharmSource Strategic Advantage

Let PharmSource be your market intelligence guide.

PharmSource’s STRATEGIC ADVANTAGE service is the industry’s most respected outsourcing information web portal for serious consumers of information on contract drug development and manufacturing. Developed from PharmSource’s expert proprietary research, you won’t find this information in any other resource.

See for yourself how this resource gives you vital tools for understanding the industry.

To request a test-drive today, contact Nathaniel Celentano at nathaniel@pharmsource.com / +1-703-383-4903, ext. 112 (ET USA).
 
 

Place your annual subscription now and receive service through January 1, 2017.